1. Introduction

Artificial womb governance refers to the legal, ethical, medical and institutional framework governing the research, development, testing and clinical use of artificial womb technology (AWT), also known as ectogenesis or ectogestation.

An artificial womb is a technology intended to support fetal development outside the human uterus. Current research has primarily focused on partial ectogestation—supporting extremely premature fetuses after transfer from the uterus—rather than complete development from conception to birth outside the human body. Human clinical use remains a developing area, and the legal framework has not yet fully adapted to it.

Cambridge University Press

+1

Artificial womb governance addresses a fundamental question: How should the law protect the developing child, the pregnant person, parents, medical professionals and society when gestation is partly or potentially entirely separated from the human body?

The subject involves constitutional law, reproductive rights, medical negligence, bioethics, product liability, research ethics, child welfare, privacy, equality and public health regulation.

2. Meaning and scope of artificial womb governance

Artificial womb governance encompasses the rules and institutions that determine:

Who may research and manufacture artificial womb systems.

Whether and under what conditions human clinical trials may proceed.

Who may consent to transferring a fetus into the system.

Who makes decisions about medical treatment, complications and withdrawal of support.

How parenthood, legal birth, citizenship and inheritance are determined.

Who bears liability when a device malfunctions or causes injury.

How the technology should be accessed fairly and protected against commercial exploitation.

Three concepts must be distinguished.

These categories cannot simply be treated as legally identical. A system designed to assist a critically premature infant may raise different issues from a hypothetical technology that replaces pregnancy entirely.

3. Principal legal issues in artificial womb governance

A. Research approval and clinical safety

Artificial womb systems involve complex biological and engineering risks, including infection, developmental injury, equipment failure and uncertainty about long-term outcomes.

Governance should therefore require:

Independent scientific and ethics review before human research.

Evidence from appropriate preclinical studies.

Clear eligibility criteria for clinical trials.

Informed consent and independent patient advocacy.

Monitoring of developmental outcomes and adverse events.

Mandatory reporting of serious incidents and research misconduct.

A central difficulty is deciding whether a developing entity supported by an artificial womb should be treated as a fetus, a neonatal patient, or a distinct category for particular legal purposes. Contemporary scholarship argues that patient-centred safeguards should apply even where the entity's precise legal status remains unsettled.

PMC

+1

B. Reproductive autonomy and bodily integrity

Artificial womb technology could provide an alternative to continuing gestation within the human body, particularly where pregnancy presents serious medical risks. However, it must not become a means of compelling a pregnant person to undergo fetal transfer or of forcing someone to continue genetic parenthood against their wishes.

The law must distinguish between:

The right to refuse medical intervention.

The right to terminate a pregnancy under applicable law.

The possibility of transferring a fetus to an artificial womb.

The separate question of whether a person retains parental responsibilities after transfer.

An artificial womb should not automatically eliminate reproductive autonomy. The availability of a technological alternative does not, by itself, establish that a person must accept that alternative.

C. Legal personhood and the status of the developing entity

Traditional legal systems frequently distinguish between prenatal life and a child who has legally been born. Artificial gestation complicates that distinction because biological development may continue outside the pregnant person's body.

Legislation will need to address:

When legal birth occurs.

Whether the same rules apply to a fetus transferred from a uterus.

Whether a developing entity can have an independent clinical representative.

How death, serious injury and medical decision-making are legally classified.

Whether existing inheritance and citizenship rules require amendment.

It would be premature to conclude that an artificial-womb-supported fetus automatically acquires full legal personhood merely because it exists outside the pregnant person's body. That question depends on the relevant jurisdiction's legislation and judicial interpretation.

D. Parental responsibility and custody

Artificial gestation may separate genetic parenthood, gestational involvement and legal parenthood more sharply than conventional pregnancy.

Potential disputes include disagreements between genetic contributors, intended parents and medical professionals over treatment, transfer, continuation of support or care after birth.

A sound framework should establish parentage through clear statutory rules rather than relying exclusively on genetics, contractual arrangements or control over the device.

E. Medical negligence and product liability

Liability may arise at several levels:

Courts would need to examine causation, foreseeability, professional standards, informed consent and the allocation of responsibility among multiple defendants. Existing medical-negligence and product-liability principles may provide a starting point, but artificial-womb-specific standards would likely be necessary.

F. Equality, access and commercialisation

If artificial womb technology becomes clinically available, access may depend on cost, geography, medical eligibility and insurance coverage. Commercial providers might also seek to influence clinical decisions through patents, service contracts or proprietary monitoring systems.

Governance should guard against discriminatory access, coercive treatment, exploitation of economically disadvantaged people and commercial control over essential reproductive healthcare.

4. Indian legal framework

India does not yet have a comprehensive, artificial-womb-specific statutory framework. Nevertheless, several existing laws are relevant by analogy or may apply to particular aspects of the technology.

1. Constitution of India

Articles 14 and 21 provide important principles concerning equality, non-arbitrariness, dignity, privacy and personal liberty. Their application to artificial gestation would depend on the facts, statutory framework and relevant judicial interpretation.

2. Assisted Reproductive Technology (Regulation) Act, 2021

This Act regulates assisted reproductive technology clinics and banks, registration, professional practices, and aspects of reproductive research and services. It is relevant to technologies involving embryos and reproductive medicine, but it should not be assumed to provide a complete approval pathway for an artificial womb.

India Code

+1

3. Surrogacy (Regulation) Act, 2021

The Act governs surrogacy and establishes regulatory institutions. Section 8 addresses the rights of children born through surrogacy. However, its statutory definition of surrogacy centres on a woman bearing and giving birth to a child, so whether and how it applies to complete ectogenesis would require legal analysis and potentially legislative clarification.

India Code

+2

4. Medical research and clinical regulation

Research approval, medical ethics oversight, clinical establishment requirements, medical-device rules and applicable professional standards may be relevant depending on the system's intended use and regulatory classification. A dedicated determination would be needed before assuming that an existing approval covers artificial gestation.

Official statutory sources:

Assisted Reproductive Technology (Regulation) Act, 2021 — Read the Act on India Code.

Surrogacy (Regulation) Act, 2021 — Read the Act on India Code.

5. Important case laws and their relevance

Important distinction: The following judgments are not direct artificial-womb rulings. They establish legal principles that may help courts and legislators address artificial gestation. Their application to this technology remains partly prospective.

Case 1: Suchita Srivastava v. Chandigarh Administration (2009)

Supreme Court of India · (2009) 9 SCC 1

Principle: Reproductive choice is an aspect of personal liberty under Article 21 of the Constitution.

The Supreme Court recognised a woman's reproductive autonomy, including decisions about whether to continue a pregnancy, within the applicable legal framework.

Relevance: Artificial-womb governance must not assume that a pregnant person can be compelled to undergo fetal transfer simply because technology might preserve fetal development. Consent, bodily integrity and reproductive choice remain central.

Case 2: K.S. Puttaswamy v. Union of India (2017)

Supreme Court of India · (2017) 10 SCC 1

Principle: Privacy is a fundamental right protected by Article 21 and other constitutional guarantees.

The judgment recognised privacy as encompassing important aspects of autonomy, dignity and personal decision-making.

Relevance: Artificial-womb systems could process genetic information, fetal health data, reproductive histories and continuous physiological measurements. Governance should therefore establish rules for data minimisation, confidentiality, authorised access, security and protection against discriminatory use.

Case 3: Baby Manji Yamada v. Union of India (2008)

Supreme Court of India · (2008) 13 SCC 518

Principle: Cross-border surrogacy can raise complex questions concerning parentage, nationality and the legal status of children.

The case arose from a surrogacy arrangement involving a Japanese intending parent and events in India. It brought international reproductive arrangements and the legal position of a resulting child before the courts.

Relevance: Artificial gestation may involve genetic contributors, intended parents, research institutions and medical providers in different jurisdictions. Clear parentage, birth registration, citizenship and responsibility rules are essential to prevent a child from being left in a legal vacuum.

Case 4: Devika Biswas v. Union of India (2016)

Supreme Court of India · (2016) 10 SCC 726

Principle: Reproductive healthcare must respect dignity, informed consent and the protection of patients against coercive or unsafe medical practices.

The case concerned serious concerns about sterilisation procedures and reproductive healthcare safeguards.

Relevance: Artificial-womb trials should not be conducted merely because a patient is vulnerable or has limited medical alternatives. Consent must be meaningful, risks explained, and oversight designed to protect people from coercion and unsafe experimentation.

Case 5: Jacob Mathew v. State of Punjab (2005)

Supreme Court of India · (2005) 6 SCC 1

Principle: The Court discussed the standards governing criminal liability for medical negligence and the need to distinguish genuine professional negligence from ordinary adverse outcomes.

Relevance: If an artificial-womb system malfunctions or medical staff make a treatment error, investigators must examine the applicable professional standard, evidence of negligence and causation. A poor outcome alone does not automatically establish criminal liability.

Case 6: Montgomery v. Lanarkshire Health Board (2015)

UK Supreme Court · [2015] UKSC 11

Principle: Informed consent requires appropriate disclosure of material risks and reasonable alternatives, assessed from the patient's perspective.

Relevance: A person considering fetal transfer to an artificial womb should receive understandable information about known risks, uncertainties, alternative treatment options and the limits of available evidence. The judgment is persuasive comparative authority, not binding law in India.

Case 7: Evans v. United Kingdom (2007)

European Court of Human Rights · Application No. 6339/05

Principle: The Court examined the conflict between reproductive autonomy and the legal requirements governing continued use of embryos created through IVF.

Relevance: Artificial-womb technology may intensify disputes about embryo use, consent withdrawal and competing reproductive interests. The case illustrates the importance of clear advance-consent rules, although it did not concern artificial wombs.

Case 8: Dobbs v. Jackson Women's Health Organization (2022)

Supreme Court of the United States · 597 U.S. 215 (2022)

Principle: The US Supreme Court held that the US Constitution does not confer a federal constitutional right to abortion under the reasoning of Roe v. Wade and Planned Parenthood v. Casey, returning substantial regulatory authority to elected representatives.

Relevance: Artificial-womb technology could affect debates about abortion, fetal viability and state interests in prenatal life. However, the judgment does not decide whether a pregnant person must accept fetal transfer or whether artificial gestation can replace abortion. Its relevance is jurisdiction-specific and comparative.

6. Comparative legal lessons

Academic analysis of artificial-womb technology identifies unresolved questions about legal personhood, abortion, liability and the development of a suitable regulatory framework.

scholarship.kentlaw.iit.edu

+2

7. Major challenges in future governance

7.1 Determining the threshold of birth

Existing legal definitions may depend on delivery, live birth or other jurisdiction-specific criteria. Artificial gestation could make these distinctions harder to apply consistently. Legislatures should clarify when birth is legally recognised and how registration, citizenship and inheritance rules operate.

7.2 Conflicts between parental and clinical authority

Parents should ordinarily participate in decisions concerning a child's treatment, but their authority is not unlimited. A legal framework must specify how conflicts are resolved where clinicians believe a proposed decision would expose the developing entity to serious harm.

7.3 Device failure and emergency transfer

A system failure could require immediate treatment, transfer to another device or conventional neonatal care. Hospitals should maintain emergency protocols, backup systems and clear responsibility for clinical decisions.

7.4 Algorithmic decision-making

If artificial-womb systems use automated monitoring or predictive software, the law should require appropriate validation, audit trails, human oversight and disclosure of relevant system limitations. Manufacturers and providers should not be able to avoid accountability merely by describing a harmful decision as an algorithmic output.

7.5 Long-term follow-up

Research governance should address developmental monitoring, privacy, retention of clinical data and the interests of children as they mature. Follow-up requirements must be scientifically justified, proportionate and consistent with applicable consent and privacy rules.

8. A proposed governance framework

A comprehensive statute or regulatory framework could include the following elements.

Licensing and classification: Establish a competent authority to classify artificial-womb systems according to intended use, risk and clinical purpose.

Research authorisation: Require independent ethics review, adequate preclinical evidence, transparent trial protocols and continuing safety monitoring.

Informed consent: Define who must consent to fetal transfer, what information must be provided, and how consent can be withdrawn before and after transfer.

Patient protection: Provide independent clinical advocacy and a clear process for resolving disputes over treatment, transfer and withdrawal of life-sustaining support.

Parentage and legal status: Clarify birth registration, parental responsibility, citizenship and inheritance without discriminating on the basis of gestational method.

Liability and insurance: Define responsibilities among hospitals, manufacturers, research institutions and software providers, including incident reporting and compensation mechanisms.

Equity and oversight: Prevent exploitation, discriminatory access and improper commercial influence, with independent audits and public accountability.

9. Conclusion

Artificial womb governance is an emerging field that requires the careful adaptation of existing legal principles rather than the assumption that traditional reproductive law already answers every question.

Indian constitutional jurisprudence on reproductive autonomy, privacy and dignity, together with the ART and Surrogacy Acts, provides a starting point. Comparative authorities on informed consent, embryo disputes and medical negligence can also help shape future regulation.

Nevertheless, no cited judgment establishes a complete legal regime for artificial wombs. The central legislative task is to protect the developing entity and the people involved, preserve meaningful reproductive choice, establish clear parentage and liability rules, and ensure that research and clinical innovation remain subject to effective public oversight.

The ultimate objective should be a framework that supports responsible medical progress without allowing technological capability to override human dignity, informed consent, equality or the rule of law.